Sangamo Therapeutics Announces Participation at Guggenheim Healthcare Talks: 2021 Genomic Medicines & Rare Disease
Sangamo Therapeutics, Inc. (Nasdaq: SGMO) will participate in the virtual Guggenheim Healthcare Talks: 2021 Genomic Medicines & Rare Disease conference on April 1, 2021. The management is set to join a panel discussion at 10 a.m. Eastern Time. The event will be webcast live and can be accessed via Sangamo's website. This engagement highlights Sangamo's commitment to advancing genomic medicines through gene therapy, cell therapy, and genome engineering, aimed at transforming patients' lives.
- Participation in a prominent healthcare conference, potentially increasing visibility.
- Opportunity for management to discuss advancements in genomic medicine.
- None.
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will participate in the virtual Guggenheim Healthcare Talks: 2021 Genomic Medicines & Rare Disease conference on April 1, 2021. Sangamo management is expected to participate in a panel discussion at 10 a.m. Eastern Time on April 1, 2021.
The event will be webcast live and available via an access link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The event will also be available on the Sangamo Therapeutics website after the event.
About Sangamo Therapeutics
Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, cell therapy, and genome engineering. For more information about Sangamo, visit www.sangamo.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210325005156/en/
FAQ
When is Sangamo's participation in the Guggenheim conference?
What time will Sangamo's panel discussion start?
How can I access the event featuring Sangamo?
What is the focus of Sangamo Therapeutics?
